Sunday, 14 January 2018 16:39

Anticoagulation news items. Week commencing 8th January 2018

Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!


Based on guideline concordance and evidence, the article concludes NOACs can be used in patients with atrial fibrillation (AF) and native valve diseases (except rheumatic mitral stenosis, due to lack of data), using standard AF risk scores and AF guidelines.



The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: